Page last updated: 2024-11-02

pentamidine and Lipodystrophy, Intestinal

pentamidine has been researched along with Lipodystrophy, Intestinal in 1 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Research Excerpts

ExcerptRelevanceReference
"Pentamidine is a group I intron splice inhibitor used as a chemotherapeutic agent to treat parasitic infections."1.37In vitro activity of pentamidine against Tropheryma whipplei. ( Fenollar, F; Raoult, D; Rolain, JM, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rolain, JM1
Fenollar, F1
Raoult, D1

Other Studies

1 other study available for pentamidine and Lipodystrophy, Intestinal

ArticleYear
In vitro activity of pentamidine against Tropheryma whipplei.
    International journal of antimicrobial agents, 2011, Volume: 38, Issue:6

    Topics: Anti-Bacterial Agents; Culture Media; Doxycycline; Humans; Microbial Sensitivity Tests; Pentamidine;

2011